Editorji is a popular short video news and information platform based in India. It was founded in 2018 by Vikram Chandra, one of India’s leading journalists, and has risen to prominence in the digital news space in a relatively short span of time. The platform is primarily designed for mobile devices, with applications available for Android and iOS.

ABOUT US:

about us editorji

Latest Video News: Editorji provides the latest news video headlines, latest videos clip from India and the World. Get all breaking news videos on Entertainment, Business, Coronavirus, Elections, Politics and more.

Latest Video News, Breaking News, Bollywood, Political, Sports, Business News | Editorji

+91 11 4035 6666 / info@editorji.com
3rd floor, Plot B, Khasara no 360, Sultanpur, New Delhi, Delhi 110030
<a title="mail to us" href="mailto:info@editorji.com">Send Feedback</a>
<a title="Contact Us" href="mailto:info@editorji.com">Contact Us</a>

REACH US

Contact for any questions, suggestions, comments, feedback or advertisement on Editorji.com, we are always looking forward to hearing from you.

Contact Us for Feedback, Suggestions and Advertising 

Editorji content is better experienced in our app.

AIMA Conclave:&nbsp;Serve the people at large and the opportunities will come automatically, said&nbsp;Adar Poonawalla, Chief Executive Officer, Serum Institute of India in conversation with Sanjiv Goenka, Chairman, RP-Sanjiv Goenka Group at&nbsp;All India Management Association&rsquo;s (AIMA) 7th National Leadership Conclave.&nbsp;
Adar&nbsp;Poonawalla mentioned he had raised Rs 10,000 crore from other countries, and philanthropists like Bill Gates in 2020 to build capacities and buy raw materials to start vaccine production.&nbsp;
However, the execution was the hardest part for him as everything was shut down during the pandemic, though the government helped in getting special visas and fast-tracking permissions and licenses.&nbsp; It was not just a financial risk for Adar Poonawalla but a reputational risk as well.
When asked why he chose&nbsp;the Oxford-developed vaccine, Adar mentioned four factors that helped him; cost-effectiveness, proven technology, thermostability, and trust factor.
Speaking at the AIMA Conclave 2022, Poonawalla said though there is a first-mover advantage, you can be second or third as well and still do great by&nbsp;learning&nbsp;from the mistakes of others.&nbsp;
Adar mentioned the new variant of coronavirus may cause some disruptions later and that is why it is important to get booster doses. &ldquo;It will reduce the chances of future lockdowns which have created distress and financial loss to everybody,&rdquo; he said.&nbsp;

AIMA 2022: Serum Institute’s Adar Poonawalla on building capacity and resilience

AIMA Conclave:&nbsp;Serve the people at large and the opportunities will come automatically, said&nbsp;Adar Poonawalla, Chief Executive Officer, Serum Institute of India in conversation with Sanjiv Goenka, Chairman, RP-Sanjiv Goenka Group at&nbsp;All India Management Association&rsquo;s (AIMA) 7th National Leadership Conclave.&nbsp;
Adar&nbsp;Poonawalla mentioned he had raised Rs 10,000 crore from other countries, and philanthropists like Bill Gates in 2020 to build capacities and buy raw materials to start vaccine production.&nbsp;
However, the execution was the hardest part for him as everything was shut down during the pandemic, though the government helped in getting special visas and fast-tracking permissions and licenses.&nbsp; It was not just a financial risk for Adar Poonawalla but a reputational risk as well.
When asked why he chose&nbsp;the Oxford-developed vaccine, Adar mentioned four factors that helped him; cost-effectiveness, proven technology, thermostability, and trust factor.
Speaking at the AIMA Conclave 2022, Poonawalla said though there is a first-mover advantage, you can be second or third as well and still do great by&nbsp;learning&nbsp;from the mistakes of others.&nbsp;
Adar mentioned the new variant of coronavirus may cause some disruptions later and that is why it is important to get booster doses. &ldquo;It will reduce the chances of future lockdowns which have created distress and financial loss to everybody,&rdquo; he said.&nbsp;

serum institute of india

Categories